Long‐term outcome in Caucasian patients with chronic hepatitis B virus infection after HBsAg seroclearance

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|35|1|140-147

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.1, 2015-01, pp. : 140-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Presence of HBV in the Sera of Chronic Hepatitis B Patients with HBsAg Seroclearance

By  

Intervirology, Vol. 50, Iss. 3, 2007-01 ,pp. : 161-165

Karger

Access to resources Recommend Favorite

Analysis of hepatitis B surface antigen (HBsAg) using high‐sensitivity HBsAg assays in hepatitis B virus carriers in whom HBsAg seroclearance was confirmed by conventional assays

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E263-E274

John Wiley & Sons Inc

Access to resources Recommend Favorite

IFNL4 rs368234815 and rs117648444 variants predict off‐treatment HBsAg seroclearance in IFN‐treated HBeAg‐negative chronic hepatitis B patients

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. 3, 2018-03 ,pp. : 417-423

John Wiley & Sons Inc

Access to resources Recommend Favorite

P064: Hepatitis B surface Antigen (HBsAg) levels in chronic hepatitis B patients ‐ a comparison between patients of different ages and their hepatitisBeAntigen (HBeAg) seroconversion status in a prospective cohort

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 52-52

John Wiley & Sons Inc

Access to resources Recommend Favorite

HDV2 O‐09: REP 2139 monotherapy and combination therapy with pegylated interferon: safety and potent reduction of HBsAg and HDV RNA in Caucasian Patients with chronic HBV/HDV co‐infection

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 5-6

John Wiley & Sons Inc

Access to resources Recommend Favorite